Connection

Barbara Wiggins to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Barbara Wiggins has written about Antibodies, Monoclonal, Humanized.
Barbara Wiggins
Connection Strength
0.136
Antibodies, Monoclonal, Humanized
  1. Evolocumab: Considerations for the Management of Hyperlipidemia. Curr Atheroscler Rep. 2018 03 06; 20(4):17.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.